Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVR NASDAQ:BBNX NASDAQ:EMBC NASDAQ:SIBN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$8.13-0.7%$9.26$2.99▼$11.06$797.23M1.651.36 million shs501,718 shsBBNXBeta Bionics$15.85-1.7%$14.53$8.80▼$32.71$718.79M3.04986,838 shs558,667 shsEMBCEmbecta$3.29+1.2%$3.24$2.77▼$15.55$195.19M0.831.69 million shs737,380 shsSIBNSiBone$16.62+0.9%$15.92$11.48▼$21.89$730.43M0.67628,991 shs381,074 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global-0.73%-3.79%-21.83%+45.70%+146.36%BBNXBeta Bionics-1.74%-8.33%+7.60%+41.90%+7.31%EMBCEmbecta+1.23%+1.23%+6.13%-64.32%-71.71%SIBNSiBone+0.91%-4.37%+1.71%+22.93%-6.42%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$8.13-0.7%$9.26$2.99▼$11.06$797.23M1.651.36 million shs501,718 shsBBNXBeta Bionics$15.85-1.7%$14.53$8.80▼$32.71$718.79M3.04986,838 shs558,667 shsEMBCEmbecta$3.29+1.2%$3.24$2.77▼$15.55$195.19M0.831.69 million shs737,380 shsSIBNSiBone$16.62+0.9%$15.92$11.48▼$21.89$730.43M0.67628,991 shs381,074 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global-0.73%-3.79%-21.83%+45.70%+146.36%BBNXBeta Bionics-1.74%-8.33%+7.60%+41.90%+7.31%EMBCEmbecta+1.23%+1.23%+6.13%-64.32%-71.71%SIBNSiBone+0.91%-4.37%+1.71%+22.93%-6.42%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVRAnteris Technologies Global 2.60Moderate Buy$16.0096.80% UpsideBBNXBeta Bionics 2.64Moderate Buy$20.3028.08% UpsideEMBCEmbecta 1.60Reduce$11.00234.35% UpsideSIBNSiBone 2.71Moderate Buy$23.5041.40% UpsideCurrent Analyst Ratings BreakdownLatest EMBC, AVR, BBNX, and SIBN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/21/2026SIBNSiBone Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)7/17/2026BBNXBeta Bionics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)7/17/2026EMBCEmbecta Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold7/16/2026SIBNSiBone Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$18.00 ➝ $21.007/15/2026BBNXBeta Bionics The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$17.00 ➝ $19.007/13/2026BBNXBeta Bionics Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$18.00 ➝ $22.007/2/2026SIBNSiBone Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/29/2026AVRAnteris Technologies Global Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/27/2026BBNXBeta Bionics The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$19.00 ➝ $17.005/18/2026BBNXBeta Bionics Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$23.00 ➝ $11.005/18/2026EMBCEmbecta Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetUnderperform$11.00 ➝ $3.00(Data available from 7/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVRAnteris Technologies Global$1.91M414.33N/AN/A($0.01) per share-813.00BBNXBeta Bionics$110.24M6.41N/AN/A$6.53 per share2.43EMBCEmbecta$1.04B0.19$4.06 per share0.81($11.12) per share-0.30SIBNSiBone$206.22M3.57N/AN/A$4.09 per share4.06Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVRAnteris Technologies Global-$94.14M-$2.23N/AN/AN/A-5,148.78%-124.76%-101.21%8/10/2026 (Estimated)BBNXBeta Bionics-$73.20M-$1.51N/AN/AN/A-60.27%-23.00%-20.55%N/AEMBCEmbecta$95.40M$1.901.731.88N/A10.73%-23.96%14.12%8/6/2026 (Estimated)SIBNSiBone-$18.90M-$0.39N/AN/AN/A-8.10%-9.56%-7.06%8/3/2026 (Estimated)Latest EMBC, AVR, BBNX, and SIBN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/10/2026Q2 2026AVRAnteris Technologies Global-$0.2073N/AN/AN/A$1.50 millionN/A8/6/2026Q3 2026EMBCEmbecta$0.26N/AN/AN/A$254.53 millionN/A8/3/2026Q2 2026SIBNSiBone-$0.15N/AN/AN/A$55.27 millionN/A5/12/2026Q1 2026AVRAnteris Technologies Global-$0.2708-$0.28-$0.0092-$0.28$0.77 million$0.49 million5/11/2026Q1 2026SIBNSiBone-$0.17-$0.10+$0.07-$0.10$51.16 million$52.59 million5/5/2026Q2 2026EMBCEmbecta$0.42$0.27-$0.15-$0.07$235.67 million$221.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAVRAnteris Technologies GlobalN/AN/AN/AN/AN/ABBNXBeta BionicsN/AN/AN/AN/AN/AEMBCEmbecta$0.041.22%N/A2.11%N/ASIBNSiBoneN/AN/AN/AN/AN/ALatest EMBC, AVR, BBNX, and SIBN DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/1/2026EMBCEmbectaquarterly$0.011.2%5/28/20265/28/20266/15/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVRAnteris Technologies GlobalN/A20.9320.93BBNXBeta BionicsN/A10.699.67EMBCEmbectaN/A2.461.68SIBNSiBone0.209.998.34Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVRAnteris Technologies GlobalN/ABBNXBeta BionicsN/AEMBCEmbecta93.83%SIBNSiBone98.11%Insider OwnershipCompanyInsider OwnershipAVRAnteris Technologies Global4.50%BBNXBeta Bionics5.30%EMBCEmbecta1.30%SIBNSiBone4.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVRAnteris Technologies Global13897.34 million92.96 millionN/ABBNXBeta Bionics29444.56 million42.20 millionN/AEMBCEmbecta1,85059.33 million58.56 millionOptionableSIBNSiBone35044.35 million42.58 millionOptionableEMBC, AVR, BBNX, and SIBN HeadlinesRecent News About These CompaniesGranahan Investment Management LLC Boosts Holdings in SiBone $SIBNJuly 25 at 6:23 AM | marketbeat.comParadigm Capital Management Inc. NY Acquires 598,300 Shares of SiBone $SIBNJuly 25 at 5:51 AM | marketbeat.comSI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026July 20, 2026 | globenewswire.comSiBone (NASDAQ:SIBN) Receives Average Rating of "Moderate Buy" from BrokeragesJuly 15, 2026 | americanbankingnews.comSiBone (NASDAQ:SIBN) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJuly 15, 2026 | marketbeat.comSiBone (NASDAQ:SIBN) Trading Down 6.5% - What's Next?July 14, 2026 | marketbeat.comViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its BoardJuly 14, 2026 | globenewswire.comMichael Pisetsky Sells 3,134 Shares of SiBone (NASDAQ:SIBN) StockJuly 7, 2026 | insidertrades.comJeffrey Dunn Sells 3,575 Shares of SiBone (NASDAQ:SIBN) StockJune 9, 2026 | insidertrades.comSI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026June 4, 2026 | globenewswire.comBears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' NowJune 3, 2026 | zacks.comSiBone (NASDAQ:SIBN) Director Timothy Davis, Jr. Sells 3,500 SharesJune 2, 2026 | insidertrades.comWall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should KnowJune 1, 2026 | zacks.comGazprom Neft says Q1 profit down 3.5% y/yMay 29, 2026 | reuters.comSiBone (NASDAQ:SIBN) SVP Sells 3,726 SharesMay 21, 2026 | insidertrades.comAnshul Maheshwari, CFO of SI-BONE, sells $60k in SIBN stockMay 15, 2026 | investing.comHow Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%May 15, 2026 | zacks.comSI-BONE targets $230M-$233M 2026 revenue while CMS proposes new DRGs that could add up to $50,000 per Granite procedureMay 14, 2026 | seekingalpha.comSI-BONE, Inc. (SIBN) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 12, 2026 | seekingalpha.comSI-BONE, Inc. (SIBN) Q1 2026 Earnings Call TranscriptMay 12, 2026 | seekingalpha.comSI-BONE, Inc. 2026 Q1 - Results - Earnings Call PresentationMay 12, 2026 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeEMBC, AVR, BBNX, and SIBN Company DescriptionsAnteris Technologies Global NASDAQ:AVR$8.13 -0.06 (-0.73%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$8.13 0.00 (0.00%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.Beta Bionics NASDAQ:BBNX$15.85 -0.28 (-1.74%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$16.12 +0.28 (+1.74%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.Embecta NASDAQ:EMBC$3.29 +0.04 (+1.23%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$3.30 +0.00 (+0.15%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.SiBone NASDAQ:SIBN$16.62 +0.15 (+0.91%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$16.61 -0.01 (-0.03%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/20- 07/24 Telecom Earnings Reveal a Sector That Finally Looks Healthier AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Defense Earnings Show Readiness Now and Modernization Ahead Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
